Granulocyte-macrophage colony-stimulating factor crosses the blood-brain and blood-spinal cord barriers

被引:83
作者
McLay, RN
Kimura, M
Banks, WA
Kastin, AJ
机构
[1] TULANE UNIV,DEPT MED,NEW ORLEANS,LA 70112
[2] VET AFFAIRS MED CTR,DEPT MED,NEW ORLEANS,LA
[3] TOKYO MED & DENT UNIV,TOKYO 113,JAPAN
关键词
blood-brain barrier; blood-spinal cord barrier; colony-stimulating factors; granulocyte-macrophage colony-stimulating factor (GM-CSF); transporters;
D O I
10.1093/brain/120.11.2083
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Granulocyte-macrophage colony-stimulating factor (GM-CSF), a glycoprotein with hormonal properties, is produced by several cell types, most of which exist outside the CNS. GM-CSF: however affects the CNS. If capable of crossing from blood to CNS GM-CSF might be an important signalling molecule between the CNS and periphery. We used an established in vivo method in mice and rats to study passage of radioactively labelled GM-CSF from blood to CNS. We found that GM-CSF crossed the blood-brain barrier and blood-spinal cord barrier significantly faster than the control substance, albumin. Labelled GM-CSF was recovered in intact form by high performance liquid chromatography from brain after peripheral injection, and passage was not significantly reduced by simultaneous injection of unlabelled L-tryptophan. Both findings indicate that the observed passage of radioactivity was intact protein. Capillary depletion experiments showed that most of the GM-CSF was deposited in brain parenchyma rather than cerebral capillary endothelium. Co-injection of unlabelled GM-CSF significantly reduced the passage rate of labelled cytokine across the blood-brain and blood-spinal cord barriers, demonstrating that passage was mediated by a saturable system. In summary, a saturable mechanism transports GM-CSF intact from blood to CNS.
引用
收藏
页码:2083 / 2091
页数:9
相关论文
共 21 条
[1]   QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS, IMMUNE ACTIVATION FACTORS, AND QUINOLINIC ACID IN AIDS BRAINS [J].
ACHIM, CL ;
HEYES, MP ;
WILEY, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2769-2775
[2]  
BALDWIN GC, 1993, BLOOD, V82, P3279
[3]  
BENVENISTE EN, 1994, RES P ARNMD, V72, P71
[4]  
BURGESS AW, 1977, J BIOL CHEM, V252, P1998
[5]   EMPLOYMENT OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ESOPHAGEAL CANDIDIASIS IN AIDS PATIENTS [J].
CAPETTI, A ;
BONFANTI, P ;
MAGNI, C ;
MILAZZO, F .
AIDS, 1995, 9 (12) :1378-1379
[6]   DIFFERENTIATION DRIVEN BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ENDOWS MICROGLIA WITH INTERFERON-GAMMA-INDEPENDENT ANTIGEN PRESENTATION FUNCTION [J].
FISCHER, HG ;
NITZGEN, B ;
GERMANN, T ;
DEGITZ, K ;
DAUBENER, W ;
HADDING, U .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 42 (01) :87-96
[7]   THE IMPACT OF MICROGLIA-DERIVED CYTOKINES UPON GLIOSIS IN THE CNS [J].
GIULIAN, D ;
LI, J ;
LI, X ;
GEORGE, J ;
RUTECKI, PA .
DEVELOPMENTAL NEUROSCIENCE, 1994, 16 (3-4) :128-136
[8]   A MODEL FOR THE INTERACTION OF THE GM-CSF, IL-3 AND IL-5 RECEPTORS WITH THEIR LIGANDS [J].
GOODALL, GJ ;
BAGLEY, CJ ;
VADAS, MA ;
LOPEZ, AF .
GROWTH FACTORS, 1993, 8 (02) :87-97
[9]  
Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO
[10]  
2-E